Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
ANTI-HER2 ANTIBODY DRUG CONJUGATE PHARMACEUTICAL PREPARATION

No-Receipt date 2024-00797 - 27/02/2024
No-Filing date 20240400515 - 27/02/2024
No-Granting date 3114815 - 05/03/2024
No-EPO application date 20776430.9 - 25/03/2020
No-EPO granting date 3811979 - 29/11/2023
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 3/2024 - 10/04/2024
Expiration date 26/03/2040
Kind of title Validation of European Patent
Legal status VALID
Priorities CN20191023120326/03/2019/CN
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61P 35/00
A61K 9/19
A61K 9/08
A61K 47/68
A61K 47/65
A61K 47/20
A61K 39/395
A61K 38/00

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1586740 REMEGEN CO., LTD. CHINA (SHANDONG) PILOT FREE TRADE ZONE YANTAI DISTRICT, YANTAI DEVELOPMENT ZONE NO.58 BEIJING MIDDLE ROADSHANDONG 264006 CHINA (PEOPLE'S REPUBLIC OF)

Inventors
CodeFirstnameSurname
4128818 LI, ZHUANGLIN
4128819 XU, QIAOYU
4128820 YAO, XUEJING
4128821 BAO, QIANJING
4128822 FANG, JIANMIN

Representatives
CodeFirstnameSurnameAddressTownZip
745CHRISTINAKIORTSISOLONOS 136ATHINA (ATTIKIS)10677

Contact
CodeFirstnameSurnameAddressTownZipCountry
2126CHRISTINAKIORTSISOLONOS 136ATHINA (ATTIKIS)10677 GREECE

Owners History

Title Instruments

Payments history 6 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015